Figure 2.

Kaplan-Meier disease-free survival plots of patients presenting with clinically confined ccRCC whose primary tumours were stratified as positive (+) or negative (-) for expression of p4E-BP1 (A), eIF4E (B), co-expression of p4E-BP1 and eIF4E (C), and sub-analysis (D) of patients who were either negative for both p4E-BP1 and eIF4E; positive for p4E-BP1 alone; positive for eIF4E alone; positive for both biomarkers. Patients whose tumours expressed both p4E-BP1 and eIF4E had significantly worse prognosis.